MedTrace Logo

Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries

NCT06717490 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-12-05

No results posted yet for this study

Summary

This will be a prospective randomized, double-blind study, aiming at investigating the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia

Conditions

  • Magnesium Sulfate
  • Thromboelastometry

Interventions

DRUG

Magnesium sulphate

In patients allocated to the MS group, a fixed dose of magnesium sulfate diluted in a fixed volume of natural saline will be administered intravenously. Thromboelastometry will be performed pre and post magnesium administration.

OTHER

Placebo Drug

In patients allocated to the NS group, a fixed dose of natural saline will be administered intravenously, through a fixed volume of solution. Thromboelastometry will be performed pre and post magnesium administration.

Sponsors & Collaborators

  • Aretaieion University Hospital

    collaborator OTHER

  • Marianna Mavromati

    lead OTHER

Principal Investigators

  • Kassiani Theodoraki, Professor · Aretaieio University Hospital, National and Kapodistrian University of Athens

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06717490 on ClinicalTrials.gov